Have a personal or library account? Click to login

References

  1. Kim SH, Chung HC, Jeong J, Kim JH, Rha SY, Ahn JB, et al. A locally advanced breast cancer with difficult differential diagnosis of carcinosarcoma and atypical medullary carcinoma, which had poor response to adriamycin- and taxane-based neoadjuvant chemotherapy. Cancer Res Treat 2007; 39:134–7.
  2. Gutman H, Pollock RE, Janjan NA, Johnson DA. Biologic distinctions and therapeutic implications of sarcomatoid metaplasia of epithelial carcinoma of the breast. J Am Coll Surg 1995; 180:193–199.
  3. Foschini MP, Dina RE, Eusebi V. Sarcomatoid neoplasms of the breast: Proposed definitions for biphasic and monophasic sarcomatoid mammary carcinomas. Semin Diagn Pathol 1993; 10:128–136.
  4. Rosai J. Special techniques in surgical pathology. Rosai and Ackerman's Surgical Pathology, Mosby Ninth edition. 2004; 1810–1812.
  5. Tseng WH, Martinez SR. Metaplastic breast cancer: to radiate or not to radiate? Ann Surg Oncol 2011; 18:94–103.
  6. Wargotz ES, Norris HJ. Metaplastic carcinomas of the breast. III. Carcinosarcoma. Cancer 1989; 64:1490–9.
  7. Harris M, Persaud V. Carcinosarcoma of the breast. J Pathol 1974; 112:99–105.
  8. Tampaki EC, Tampakis A, Agrogiannis G, Kavantzas N, Kontzoglou K, Kouraklis G. A Case of Positive Mixed Epithelial/Mesenchymal Metaplastic Breast Carcinoma (Carcinosarcoma). Towards Novel Therapeutic Targets. Case Report Onkologie 2013; 36:506–509.
  9. WHO Classification of Tumors Editorial Board, ed. WHO classification of tumors, 5th edition – Breast tumors. Lyon: International Agency for Research on Cancer 2019.
  10. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2:442–54.
  11. Azzopardi JG. Problems in breast pathology. Philadelphia: WB Saunders 1979; 373–378.
  12. Esses KM, Hagmaier RM, Blanchard SA, Lazarchick JJ, Riker AI. Carcinosarcoma of the breast: two case reports and review of the literature. Cases Journal 2009; 2:15.
  13. Atahan K, Gur S, Tarcan E. Carcinosarcoma of the breast. J Breast Health 2007; 3:85–6.
  14. Abbasi MA, Mahmood H, Faheem M, Khan KA and Irfan J. Carcinosarcoma of the Breast. J Coll Physicians Surg Pak 2012; 22:333–334.
  15. Takudome N, Sakamoto G, Sakai T, Sarumaru S, Okuyama N, Hori F et al. A Case of Carcinosarcoma of the Breast. Breast Cancer 2005; 12:149–153.
  16. Koufopoulos N, Kokkali S, Antoniadou F, Dimas D, Missitzis I. Matrix-producing Breast carcinoma: A Rare Subtype of Metaplastic Breast Carcinoma. Cureus. 2019 Jul 22; 11(7):e5188.
  17. Koufopoulos N, Kokkali S, Antoniadou F, et al. EP213 Undifferentiated pleomorphic sarcoma of the breast: presentation of a case. International Journal of Gynecologic Cancer 2019; 29:A182–A183.
  18. Duran-Moreno J, Kokkali S, Ramfidis V, et al. Primary Sarcoma of the Lung Prognostic Value of Clinicopathological Characteristics of 26 Cases. Anticancer Res. 2020; 40(3):1697–1703
  19. Bajpai J, Punatar SB, Gupta A, Badwe R, Gupta S. Bilateral adenomyoepithelioma of breast. J Cancer Res Ther. 2013; 9(3):523–5.
  20. Tse GM, Tan PH, Putti TC, Lui PC, Chaiwun B, Law BK. Metaplastic carcinoma of the breast: a clinicopathologic review. J Clin Pathol 2006; 59:1079–83.
  21. Chao TC, Wang CS, Chen SC, et al. Metaplastic carcinomas of the breast. J Surg Oncol 1999; 71:220–5.
  22. Rayson D, Adjei AA, Suman VJ, et al. Metaplastic breast cancer: prognosis and response to systemic therapy. Ann Oncol 1999; 10:413–9.
  23. Kim SH, Chung HC, Jeong J, Kim JH, Rha SY, Ahn JB, et al. A locally advanced breast cancer with difficult differential diagnosis of carcinosarcoma and atypical medullary carcinoma, which had poor response to adriamycin- and taxane-based neoadjuvant chemotherapy. Cancer Res Treat 2007; 39:134–7.
  24. Al Sayed AD, El Weshi AN, Tulbah AM, Rahal MM, Ezzat AA. Metaplastic carcinoma of the breast clinical presentation, treatment results and prognostic factors. Acta Oncol 2006; 45: 188–95.
  25. Tse GM, Tan PH, Putti TC, Lui PC, Chaiwun B, Law BK. Metaplastic carcinoma of the breast: a clinicopathological review. J Clin Pathol 2006; 59:1079–83.
  26. Sneige N, Yaziji H, Mandavilli SR, Perez ER, Ordonez NG, Gown AM, Ayala A. Low-grade (fibromatosis-like) spindle cell carcinoma of the breast. Am J Surg Pathol 2001; 25:1009–16.
  27. Shah DR, Tseng WH, Martinez SR. Treatment options for metaplastic breast cancer. ISRN Oncol 2012; 2012:706162.
  28. Leibl S, Moinfar F. Metaplastic breast carcinomas are negative for Her-2 but frequently express EGFR (Her-1): potential relevance to adjuvant treatment with EGFR tyrosine kinase inhibitors. J Clin Pathol 2005; 7:700–4.
DOI: https://doi.org/10.2478/fco-2022-0006 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Language: English
Page range: 48 - 52
Submitted on: Jul 14, 2022
Accepted on: Dec 22, 2023
Published on: Mar 27, 2023
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 times per year

© 2023 Maria Kiakou, Maria Tolia, Nektarios Koufopoulos, Konstantinos Tsapakidis, Eleni Arvanitou, Gkikas Konstantinos, Nikolaos Charalambakis, Michalis Nikolaou, Dimitrios Matthaios, Nikolaos Tsoukalas, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.